Christopher Schaber
Vorstandsvorsitzender bei SOLIGENIX, INC.
Vermögen: 2 566 $ am 30.04.2024
Aktive Positionen von Christopher Schaber
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
SOLIGENIX, INC. | Vorstandsvorsitzender | 01.08.2006 | - |
Vorsitzender | 08.10.2009 | - | |
Präsident | 01.08.2006 | - | |
The National Organization for Rare Disorders, Inc.
The National Organization for Rare Disorders, Inc. Services to the Health IndustryHealth Services The National Organization for Rare Disorders, Inc. operates as a non-profit federation of voluntary health organizations to help individuals with diseases and disorders. Its services are focused on the identification, treatment, and cure of disorders through programs of education, advocacy, research, and service. The company was founded in 1983 and is headquartered in Danbury, CT. | Corporate Officer/Principal | 17.08.2010 | - |
American Society for Blood & Marrow Transplantation | Corporate Officer/Principal | 17.08.2010 | - |
Alliance for Biosecurity | Direktor/Vorstandsmitglied | 01.10.2014 | - |
BioNJ, Inc.
BioNJ, Inc. Miscellaneous Commercial ServicesCommercial Services BioNJ, Inc. is based in Trenton, NJ. BioNJ, Inc. is a life sciences trade association with nearly 400 member companies. The company supports the discovery, development, and commercialization of therapies and cures that save and improve lives. BioNJ drives capital formation, fosters entrepreneurship, advocates for medical innovation, provides access to talent and education, and offers critical commercial resources. The company also serves as a clearinghouse for funding information and opportunities. The company was founded in 1994 by James J. Marino, Jayne C. Gershkowitz, Abraham Abuchowski. The CEO is Debbie Hart. | Direktor/Vorstandsmitglied | - | - |
Vorsitzender | 01.02.2019 | - |
Karriereverlauf von Christopher Schaber
Ehemalige bekannte Positionen von Christopher Schaber
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
WINDTREE THERAPEUTICS, INC. | Geschäftsführer | 01.01.1998 | 01.01.2006 |
Discovery Laboratories, Inc. | Geschäftsführer | 01.01.1998 | 01.01.2006 |
Acute Therapeutics, Inc. | Compliance Officer | 01.01.1996 | 01.01.1998 |
Gründer | 01.01.1996 | 01.01.1998 | |
General Counsel | 01.01.1996 | 01.01.1998 | |
Ohmeda PPD, Inc. | General Counsel | 01.01.1994 | 01.01.1996 |
░░░░░░░░░░░ ░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ | - |
Ausbildung von Christopher Schaber
McDaniel College | Undergraduate Degree |
Union Institute & University | Doctorate Degree |
Temple University School of Pharmacy | Graduate Degree |
Statistik
International
Vereinigte Staaten | 14 |
Operativ
Director/Board Member | 3 |
Chief Operating Officer | 2 |
Chairman | 2 |
Sektoral
Consumer Services | 4 |
Health Technology | 3 |
Commercial Services | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 2 |
---|---|
SOLIGENIX, INC. | Health Technology |
WINDTREE THERAPEUTICS, INC. | Health Technology |
Private Unternehmen | 8 |
---|---|
BioSecurity Technologies, Inc.
BioSecurity Technologies, Inc. Miscellaneous Commercial ServicesCommercial Services BioSecurity Technologies, Inc. is engaged in acquiring intellectual properties for the purpose of developing commercial potential through licensure and sale. The firm specializes in the areas of homeland security, national defense, and technology applications. The company is headquartered in Richmond, VA. | Commercial Services |
Acute Therapeutics, Inc. | |
The National Organization for Rare Disorders, Inc.
The National Organization for Rare Disorders, Inc. Services to the Health IndustryHealth Services The National Organization for Rare Disorders, Inc. operates as a non-profit federation of voluntary health organizations to help individuals with diseases and disorders. Its services are focused on the identification, treatment, and cure of disorders through programs of education, advocacy, research, and service. The company was founded in 1983 and is headquartered in Danbury, CT. | Health Services |
American Society for Blood & Marrow Transplantation | |
Ohmeda PPD, Inc. | |
BioNJ, Inc.
BioNJ, Inc. Miscellaneous Commercial ServicesCommercial Services BioNJ, Inc. is based in Trenton, NJ. BioNJ, Inc. is a life sciences trade association with nearly 400 member companies. The company supports the discovery, development, and commercialization of therapies and cures that save and improve lives. BioNJ drives capital formation, fosters entrepreneurship, advocates for medical innovation, provides access to talent and education, and offers critical commercial resources. The company also serves as a clearinghouse for funding information and opportunities. The company was founded in 1994 by James J. Marino, Jayne C. Gershkowitz, Abraham Abuchowski. The CEO is Debbie Hart. | Commercial Services |
Alliance for Biosecurity | |
Discovery Laboratories, Inc. |
- Börse
- Insiders
- Christopher Schaber
- Erfahrung